IP Library Granted Patent US 11,027,123
Granted Patent B2
US 11,027,123 · App. 16/251,482 · Granted Jun 8, 2021

Systems and methods to place one or more leads in tissue to electrically stimulate nerves of passage to treat pain

Inventors: Joseph W. Boggs (Chapel Hill, NC); Rosemary H. Zang (Avon Lake, OH)
Assignee: SPR THERAPEUTICS, INC.
A61N1/0551A61N1/0456A61N1/0502A61N1/0558A61N1/36021A61N1/36071A61B5/061A61N1/36017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,027,123
App. No.
16/251,482
Granted
Jun 8, 2021
Kind
B2
Abstract

Systems and methods are provided for applying electrical stimulation to a body by an electrode spaced from a target nerve of passage. It has been discovered that pain felt, or perceived to be felt, in a given region of the body can be treated by stimulating muscle close to a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt, such as in a case of post-amputation residual limb pain, or purportedly felt in the case of post-amputation phantom limb pain.

Claims (35)

1. A system comprising:

an electrode positioned in tissue a distance spaced from (i) at least one of a Type Ia and Ib afferent nerve fibers and (ii) at least one of Type III and Type IV nerve fibers; and

an electrical stimulation device operatively coupled with the electrode, wherein the electrical stimulation device delivers electrical stimulation through the electrode to selectively activate at least one of the Type Ia and Ib afferent nerve fibers while minimizing recruitment of activation of the at least one of the Type III and Type IV nerve fibers because the electrode is spaced the distance from the at least one of a Type Ia and Ib afferent nerve fibers and the at least one of Type III and Type IV nerve fibers to reduce a perception of pain.

2. The system of claim 1 further comprising a lead comprising at least one conductive wire, the lead positioned between the electrode and the electrical stimulation device.

3. The system of claim 1 , wherein the electrode is positioned on a distal end of a coiled fine wire lead.

4. The system of claim 1 , wherein the lead is a percutaneous lead.

5. The system of claim 1 , wherein the lead is coiled fine wire lead.

6. The system of claim 1 , wherein the electrical stimulation device comprises an implantable pulse generator.

7. The system of claim 1 , wherein the electrical stimulation device comprises an external pulse generator.

8. A system comprising:

an electrode positioned in tissue in electrical proximity to but spaced away from a neural fiber bundle within a body, wherein the neural fiber bundle comprises at least one of a Type Ia and Ib afferent nerve fiber and an efferent nerve fiber; and

an electrical stimulation device delivering electrical stimulation from the electrode to the neural fiber bundle to reduce a perception of pain, wherein the at least one of Type Ia and Ib afferent nerve fiber of the neural fiber bundle are selectively activated while minimizing recruitment of activation of the efferent nerve fiber of the neural fiber bundle because the electrode is in electrical proximity but spaced away from the neural fiber bundle to reduce a perception of pain.

9. The system of claim 8 , wherein selectively activating at least one of the Type Ia and Ib afferent nerve fibers includes selectively activating both of the Type Ia and Ib afferent nerve fibers.

10. he system of claim 8 , wherein minimizing recruitment of activation includes minimizing recruitment of activation of at least one of a Type III and Type IV nerve fiber of the neural fiber bundle.

11. The system of claim 8 , wherein minimizing recruitment of activation includes minimizing recruitment of activation of both the Type III and Type IV nerve fibers of the neural fiber bundle.

12. The system of claim 8 , wherein the electrode is a monopolar electrode.

13. The system of claim 8 , wherein the electrical proximity to but spaced away from a neural fiber bundle comprises 0.5 to 3 cm from the neural fiber bundle.

14. The system of claim 8 wherein the electrode is a percutaneous electrode.

15. The system of claim 8 , wherein the electrode is positioned on a distal end of a coiled fine wire lead.

16. The system of claim 8 , wherein the lead is a percutaneous lead.

17. The system of claim 8 , wherein the lead is coiled fine wire lead.

18. The system of claim 8 , wherein the electrical stimulation device comprises an implantable pulse generator.

19. The system of claim 8 , wherein the electrical stimulation device comprises an external pulse generator.

20. A system comprising:

an electrode positioned at a therapeutically effective distance from a neural fiber bundle within tissue, wherein the neural fiber bundle comprises more than one type of nerve fiber;

an electrical stimulation device operatively coupled with the electrode, the electrical stimulation delivers electrical stimulation from the electrode to the neural fiber bundle to reduce a perception of pain by said human, wherein a first of the type of nerve fiber is selectively activated while minimizing recruitment of activation of a second of the type of nerve fiber because the electrode is at the therapeutically effective distance and wherein the electrical stimulation evokes paresthesia in a region of pain, wherein the region of pain is spaced from the electrode.

21. The system of claim 20 , wherein the therapeutically effective distance is 0.2 centimeters to 3.0 centimeters from the neural fiber bundle.

22. The system of claim 20 , wherein the first type of the type of nerve fiber comprises at least one of Type Ia and Ib afferent nerve fibers and the second of the type of nerve fiber comprises at least one of a Type III, Type IV and efferent nerve fibers.

23. The system of claim 20 further comprising an introducer needle, wherein the electrode is placed using the introducer needle percutaneously inserted into the tissue.

24. The system of claim 20 wherein the electrode is a percutaneous electrode.

25. The system of claim 20 , wherein the electrode is positioned on a distal end of a coiled fine wire lead.

26. The system of claim 20 , wherein the lead is a percutaneous lead.

27. The system of claim 20 , wherein the lead is coiled fine wire lead.

28. The system of claim 20 , wherein the electrical stimulation device comprises an implantable pulse generator.

29. The system of claim 20 , wherein the electrical stimulation device comprises an external pulse generator.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2021
From: BOGGS, JOSEPH W.; ZANG, ROSEMARY H.
To: SPR THERAPEUTICS, INC.
Reel/Frame 056137/0213 →
Continuity (9)
Continuation 15898889 · Feb 19, 2018
Continuation 13605653 · Sep 6, 2012
Continuation In Part 12653023 · Dec 7, 2009
Continuation In Part 13294875 · Nov 11, 2011
Continuation In Part 12653029 · Dec 7, 2009
Provisional Application 61531462 · Sep 6, 2011
Provisional Application 61201030 · Dec 5, 2008
Provisional Application 61412685 · Nov 11, 2010
Related Publication 20190151652A1 · May 23, 2019
Cited By (2)
US 12,350,490 US 12,636,489